Alligator Bioscience
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Alligator Bioscience is a clinical-stage biotechnology company focused on developing tumor-directed immuno-oncology antibody drugs. The company specializes in creating antibody-based pharmaceuticals for cancer treatment, with a primary focus on activating the CD40 receptor pathway to stimulate a patient's immune system against tumors. Its lead candidate, mitazalimab, is a CD40 agonist in late-stage clinical development for pancreatic cancer. Alligator Bioscience's business model is centered on advancing its pipeline of novel drug candidates through discovery, preclinical, and clinical development stages to commercialization.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Alligator Bioscience.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-27 21:00 |
Share Issue/Capital Change
Exercise price determined for the exercise of warrants series TO 13 in Alligato…
|
English | 72.6 KB | |
| 2025-08-27 21:00 |
Share Issue/Capital Change
Teckningskurs fastställd för nyttjandet av teckningsoptioner serie TO 13 i Alli…
|
Swedish | 72.8 KB | |
| 2025-07-21 12:18 |
Major Shareholding Notification
|
Swedish | 10.9 KB | |
| 2025-07-17 11:38 |
Major Shareholding Notification
|
Swedish | 10.9 KB | |
| 2025-07-10 10:49 |
Major Shareholding Notification
|
Swedish | 10.9 KB | |
| 2025-07-10 08:00 |
Interim Report
|
Swedish | 1.2 MB | |
| 2025-07-10 08:00 |
Interim Report
|
English | 1.2 MB | |
| 2025-06-30 15:00 |
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Alligator Bioscience AB
|
Swedish | 54.8 KB | |
| 2025-06-30 15:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Alligator Bioscience AB
|
English | 54.1 KB | |
| 2025-06-26 10:21 |
Major Shareholding Notification
|
Swedish | 9.9 KB | |
| 2025-06-25 10:35 |
Major Shareholding Notification
|
Swedish | 11.1 KB | |
| 2025-06-23 14:35 |
Major Shareholding Notification
|
Swedish | 11.1 KB | |
| 2025-06-19 10:42 |
Major Shareholding Notification
|
Swedish | 11.1 KB | |
| 2025-06-11 11:33 |
Major Shareholding Notification
|
Swedish | 11.1 KB | |
| 2025-06-09 12:10 |
Major Shareholding Notification
|
Swedish | 10.6 KB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-01-26 | Per Norlén | Other | Buy | 141,600 | 849,600.00 SEK |
| 2020-10-26 | Marie Svensson | Other | Buy | 1,000 | 8,740.00 SEK |
| 2020-02-21 | Per-Olof Schrewelius | Other | Buy | 10,000 | 86,000.00 SEK |
